T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties - PubMed (original) (raw)
Review
T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties
K Takatsu et al. Immunol Rev. 1988 Feb.
Abstract
TRF has originally been defined as a T-cell-derived lymphokine that triggers activated B cells for a terminal differentiation into Ig-secreting cells. HPLC-purified TRF from Sup of a murine TRF-producing B151 cell is an acidic glycoprotein, exerts BCGF II activity and induces expression of IL-2 receptors. It does not show IL-1, IL-2, IL-3, BSF-1/IL-4, or IFN gamma activity. We prepared monoclonal TB13 and NC17 antibodies against HPLC-purified B151-TRF which are specific for and can inhibit TRF as well as BCFG II activity of B151-TRF. Moreover, TB13 as well as NC17 antibody can immunoprecipitate the 46 Kd molecule from B151 Sup which exerts TRF as well as BCGF II activity. Complementary DNA (pSP6K-mTRF23) encoding for murine TRF/IL-5 was cloned and its entire nucleotide sequences were determined. The murine TRF/IL-5 cDNA encodes 133 amino acids including N-terminal strongly hydrophobic regions. Secreted recombinant TRF/IL-5 (apparent m.w. of 46 Kd) has 113 amino acid residues and also comprises homodimers of a molecule with an apparent m.w. of 25 to 30 Kd. TRF/IL-5 mRNA is constitutively expressed in constitutively TRF-producing B151 and is inducible in some T cell lines upon stimulation with PMA or Con A. TRF/IL-5 mRNA is also expressed in Tbc-primed T cells upon the stimulation with PPD, whereas its expression is not effectively induced in non-primed spleen cells by stimulation with Con A or PMA plus calcium ionophore. The translation product of murine TRF/IL-5 cDNA triggers resting as well as activated (DNP-primed or LPS-stimulated) murine B cells for terminal differentiation into Ig-secreting cells (IgM, IgG1, or IgA) accompanied by increased mRNA expression for secreted forms of relevant Ig heavy chain (mu, gamma, or alpha). Among these, increases in the level of mu, and alpha-specific mRNA for the secreted form of IgM and IgA, respectively, are prominent. Moreover, TRF/IL-5 induces maturation of resting B cells into IgM-secreting cells. TRF/IL-5 promotes growth of activated B cells as well as BCL1 cells. TRF/IL-5 is, therefore, a growth as well as a differentiation inducing factor for B cells. Moreover, it induces functional IL-2 receptors on resting as well as activated B cells, besides TRF and BCGF II activities.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- T cell replacing factor/interleukin 5 induces not only B-cell growth and differentiation, but also increased expression of interleukin 2 receptor on activated B-cells.
Harada N, Matsumoto M, Koyama N, Shimizu A, Honjo T, Tominaga A, Takatsu K. Harada N, et al. Immunol Lett. 1987 Jul;15(3):205-15. doi: 10.1016/0165-2478(87)90026-5. Immunol Lett. 1987. PMID: 3117678 - Molecular properties and regulation of mRNA expression for murine T cell-replacing factor/IL-5.
Tominaga A, Matsumoto M, Harada N, Takahashi T, Kikuchi Y, Takatsu K. Tominaga A, et al. J Immunol. 1988 Feb 15;140(4):1175-81. J Immunol. 1988. PMID: 2893824 - Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.
Harada N, Takahashi T, Matsumoto M, Kinashi T, Ohara J, Kikuchi Y, Koyama N, Severinson E, Yaoita Y, Honjo T, et al. Harada N, et al. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4581-5. doi: 10.1073/pnas.84.13.4581. Proc Natl Acad Sci U S A. 1987. PMID: 2440025 Free PMC article. - T cell-derived B cell growth and differentiation factors.
Romagnani S. Romagnani S. Ric Clin Lab. 1987 Jul-Sep;17(3):181-97. doi: 10.1007/BF02912531. Ric Clin Lab. 1987. PMID: 3313664 Review. - T-independent activation of single B cells: an orderly analysis of overlapping stages in the activation pathway.
Pike BL, Alderson MR, Nossal GJ. Pike BL, et al. Immunol Rev. 1987 Oct;99:119-52. doi: 10.1111/j.1600-065x.1987.tb01175.x. Immunol Rev. 1987. PMID: 3315967 Review.
Cited by
- Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases.
Antosz K, Batko J, Błażejewska M, Gawor A, Sleziak J, Gomułka K. Antosz K, et al. Biomedicines. 2024 Jul 10;12(7):1531. doi: 10.3390/biomedicines12071531. Biomedicines. 2024. PMID: 39062104 Free PMC article. Review. - Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon.
Wang P, Mo Z, Zhang Y, Guo C, Chikede TK, Chen D, Lei Z, Gao Z, Zhang Q, Tong Q. Wang P, et al. Front Immunol. 2023 Jan 5;13:1104329. doi: 10.3389/fimmu.2022.1104329. eCollection 2022. Front Immunol. 2023. PMID: 36685563 Free PMC article. - Neutrophil membrane-camouflaged nanoparticles alleviate inflammation and promote angiogenesis in ischemic myocardial injury.
Han D, Wang F, Qiao Z, Wang B, Zhang Y, Jiang Q, Liu M, Zhuang Y, An Q, Bai Y, Shangguan J, Zhang J, Liang G, Shen D. Han D, et al. Bioact Mater. 2022 Nov 28;23:369-382. doi: 10.1016/j.bioactmat.2022.11.016. eCollection 2023 May. Bioact Mater. 2022. PMID: 36474655 Free PMC article. - Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
Roider J, Porterfield JZ, Ogongo P, Muenchhoff M, Adland E, Groll A, Morris L, Moore PL, Ndung'u T, Kløverpris H, Goulder PJR, Leslie A. Roider J, et al. Front Immunol. 2019 Jul 2;10:1497. doi: 10.3389/fimmu.2019.01497. eCollection 2019. Front Immunol. 2019. PMID: 31333650 Free PMC article. - Evaluation of Different Stabilizers and Inactivating Compounds for the Enhancement of Vero Cell Rabies Vaccine Stability and Immunogenicity: In Vitro Study.
Olayan E, El-Khadragy M, Mohamed AF, Mohamed AK, Shebl RI, Yehia HM. Olayan E, et al. Biomed Res Int. 2019 Mar 17;2019:4518163. doi: 10.1155/2019/4518163. eCollection 2019. Biomed Res Int. 2019. PMID: 31008105 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous